Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Garcia Weight Loss, Aesthetics & Hormone Therapy vs Pomegranate Health

vs+10.000000000000007
Pomegranate Health
Graded #122

Higher grade

The verdict

Pomegranate Health takes it — 69.4/100 to 59.4/100.

Pomegranate Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Pomegranate Health sells compounded semaglutide and tirzepatide with no membership and no consultation fee.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePomegranate Health +50
30
80
Dose & formulationPomegranate Health +12
52
64
Clinical oversightPomegranate Health +3
79
82
Labs & monitoringGarcia Weight Loss, Aesthetics & Hormone Therapy +44
97
53
FulfillmentPomegranate Health +9
56
65
Contract termsEven
55
55
Garcia Weight Loss, Aesthetics & Hormone Therapy · left barPomegranate Health · right bar

The numbers

MetricGarcia Weight Loss, Aesthetics & Hormone TherapyPomegranate Health
WeighScore59.4/10069.4/100
GradeCC
Scorecard rank#342#122
Semaglutide$400/mo (starting dose, compounded)$119/mo (starting price, compounded)
TirzepatideNot disclosed$149/mo (Starter tier, compounded)
Coverage1 stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

Strengths

  • Established since 2000 with 4 Tampa Bay locations and 50,000+ patients treated
  • GLP-1 program includes full metabolic and hormone lab panel
  • Medication and supplies shipped directly to your door from partner pharmacy
  • Free 15-minute consultation; both weekly-visit (Premier) and monthly-visit (Standard) tiers
  • LegitScript transparency certification listed in footer

Where it loses points

  • Florida only — 4 locations in Tampa Bay metro area only
  • Pricing not publicly listed on website ($400/month per Facebook ad)
  • Specific GLP-1 drug (semaglutide vs tirzepatide) not disclosed on site
  • Telemedicine availability not confirmed on site despite Facebook ad claims
  • In-person visit model less convenient than fully online telehealth providers
Pomegranate Health

Graded #122 · C

Strengths

  • No membership and no consultation fee — the site states 'No Membership required' and 'Transparent pricing, no hidden fees'
  • The semaglutide price sits in the product page's own static HTML, so it can be read before any intake
  • Shipping is included: 'shipped discreetly to your door at no extra cost'
  • Both semaglutide and tirzepatide are offered

Where it loses points

  • The tirzepatide price is not on the public site at all — it exists only inside the in-app pricing portal, and there is no standalone tirzepatide product page to read it from
  • Both published figures are floors, a 'Starts @' and a Starter tier, and no price is published for the dose you titrate up to
  • The states it can prescribe in are not disclosed anywhere; the dataset's own note records that semaglutide was unavailable in CA, IA and WI
  • Klarna, Afterpay and Affirm are offered at checkout, so any monthly figure seen in a financing widget is an instalment and not the medication price
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard